Distinct binding hotspots for natural and synthetic agonists of FFA4 from in silico approaches

FFA4 has gained interest in recent years since its deorphanization in 2005 and the characterization of the Free Fatty Acids receptors family for their therapeutic potential in metabolic disorders. The expression of FFA4 (also known as GPR120) in numerous organs throughout the human body makes this receptor a highly potent target, particularly in fat sensing and diet preference. This offers an attractive approach to tackle obesity and related metabolic diseases. Recent cryo-EM structures of the receptor have provided valuable information for a potential active state although the previous studies of FFA4 presented diverging information. We performed molecular docking and molecular dynamics simulations of four agonist ligands, TUG-891, Linoleic acid, alpha-Linolenic acid, and Oleic acid, based on a homology model. Our simulations, which accumulated a total of 2 mu s of simulation, highlighted two binding hotspots at Arg992.64 and Lys293 (ECL3). The results indicate that the residues are located in separate areas of the binding pocket and interact with various types of ligands, implying different potential active states of FFA4 and a highly adaptable binding intra-receptor pocket. This article proposes additional structural characteristics and mechanisms for agonist binding that complement the experimental structures. Homology modeling of Free Fatty Acid receptor 4 (FFA4) and molecular dynamics of agonists-FFA4 complexes have shown a new binding hotspot, Lys293, and revealed a different binding preference for Lys293 or the already known Arg99 between synthetic or natural ligands. image